Backed by seven clinical trials
This additional protective effect extends beyond weight loss to encompass broader health outcomes
The reason is your metabolism
Its especially helpful during recovery, post-illness, or after heavy toxin exposure
Amongst these GLP-1 agonists, Ozempic is the most popular, making up approximately 37 }, Research And Markets, (2024), Global GLP-1 Receptor Agonist (Ozempic, Rybelsus, Trulicity, Saxenda, Wegovy, Victoza, Mounjaro, Zepbound) Market Analysis Report 2024-2030 Featuring Eli Lilly And C, Sanofi, Novo Nordisk, AstraZeneca